Corticosteroids and open-angle glaucoma in the elderly: A population-based cohort study

Drugs and Aging

Volumn 29, Issue 12, 2012, Pages 963-970

  Marcus, Michael W ^a   Müskens, Rogier P H M ^a   Ramdas, Wishal D ^b   Wolfs, Roger C W ^b   De Jong, Paulus T V M ^b,c,d   Vingerling, Johannes R ^b   Hofman, Albert ^b   Stricker, Bruno H C ^b   Jansonius, Nomdo M ^a,b  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c NETHERLANDS INSTITUTE FOR NEUROSCIENCE   (Netherlands)

^d ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

STEROID;

AGED; ARTICLE; ASSOCIATION; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG USE; FAMILY HISTORY; FEMALE; FOLLOW UP; GERIATRIC DISORDER; HIGH MYOPIA; HUMAN; INCIDENCE; INTRAOCULAR PRESSURE; MAJOR CLINICAL STUDY; MALE; OINTMENT; OPEN ANGLE GLAUCOMA; OPTIC NERVE; OUTCOME ASSESSMENT; PERIMETRY; PRESCRIPTION; PRIORITY JOURNAL; PROSPECTIVE STUDY;

ADRENAL CORTEX HORMONES; AGED; ANALYSIS OF VARIANCE; COHORT STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GLAUCOMA, OPEN-ANGLE; HUMANS; MALE;

EID: 84874587547     PISSN: 1170229X     EISSN: 11791969     Source Type: Journal    
DOI: 10.1007/s40266-012-0029-9     Document Type: Article

References (74)

1. Leibowitz HM, Kupferman A. Antiinflammatory medications. Int Ophthalmol Clin. 1980;20:117-34.
2. Sherif Z, Pleyer U. Corticosteroids in ophthalmology: past-present-future. Ophthalmologica. 2002;216:305-15. (Pubitemid 44858336)
3. Francois J. Cortisone et tension oculaire. Ann Ocul (Paris). 1954;187:805-16.
4. Goldmann H. Cortisone glaucoma. Arch Ophthalmol. 1962;68:621-6.
5. Mills DW, Oliver GL. Corticosteroid glaucoma. Can Med Assoc J. 1965;92:1084-5.
6. Cubey RB. Glaucoma following the application of corticosteroid to the skin of the eyelids. Br J Dermatol. 1976;95:207-8.
7. Brubaker RF, Halpin JA. Open angle glaucoma associated with topical administration of flurandrenolide to the eye. Mayo Clin Proc. 1975;50:322-6.
8. van Boxtel LA, Hardus PL, Al Hassan WS, van Voorst Vader PC, Jansonius NM. Corticosteroids and the risk of glaucoma. Ned Tijdschr Geneeskd. 2005;149:2485-9. (Pubitemid 41606349)
9. Wang JJ, Rochtchina E, Tan AG, Cumming RG, Leeder SR, Mitchell P. Use of inhaled and oral corticosteroids and the long-term risk of cataract. Ophthalmology. 2009;116:652-7.
10. Ernst P, Baltzan M, Deschênes J, Suissa S. Low-dose inhaled and nasal corticosteroid use and the risk of cataracts. Eur Respir J. 2006;27:1168-74. (Pubitemid 44914300)
11. Cumming RG, Mitchell P, Leeder SR. Use of inhaled corticosteroids and the risk of cataracts. N Engl J Med. 1997;337:8-14. (Pubitemid 27290841)
12. Armaly MF, Becker B. Intraocular pressure response to topical corticosteroids. Fed Proc. 1965;24:1274-8.
13. Becker B. Intraocular pressure response to topical corticosteroids. Invest Ophthalmol. 1965;4:198-205.
14. Kitazawa Y, Horie T. The prognosis of corticosteroid-responsive individuals. Arch Ophthalmol. 1981;99:819-23. (Pubitemid 11120550)
15. Becker B, Hahn KA. Topical corticosteroids and heredity in primary open-angle glaucoma. Am J Ophthalmol. 1964;57:543-51.
16. Paterson G. Studies of the response to topical dexamethasone of glaucoma relatives. Trans Ophthalmol Soc UK. 1965;85:295-305.
17. Becker B. Topical corticosteroid testing in glaucoma siblings. Arch Ophthalmol. 1966;76:484-7.
18. Armaly MF. Genetic factors related to glaucoma. Ann N Y Acad Sci. 1968;151:861-75.
19. Yamashita T, Kodama Y, Tanaka M, Yamakiri K, Kawano Y, Sakamoto T. Steroid-induced glaucoma in children with acute lymphoblastic leukemia: a possible complication. J Glaucoma. 2010;19:188-90.
20. Kwok AK, Lam DS, Ng JS, Fan DS, Chew SJ, Tso MO. Ocular-hypertensive response to topical steroids in children. Ophthalmology. 1997;104:2112-6. (Pubitemid 28053439)
21. Armaly MF. Statistical attributes of the steroid hypertensive response in the clinically normal eye. I. The demonstration of three levels of response. Invest Ophthalmol. 1965;4:187-97.
22. Tielsch JM, Katz J, Quigley HA, Javitt JC, Sommer A. Diabetes, intraocular pressure, and primary open-angle glaucoma in the Baltimore Eye Survey. Ophthalmology. 1995;102:48-53.
23. Podos SM, Becker B, Morton WR. High myopia and primary open-angle glaucoma. Am J Ophthalmol. 1966;62:1038-43.
24. Gaston H, Absolon MJ, Thurtle OA, Sattar MA. Steroid responsiveness in connective tissue diseases. Br J Ophthalmol. 1983;67:487-90. (Pubitemid 13066619)
25. Jones R 3rd, Rhee DJ. Corticosteroid-induced ocular hypertension and glaucoma: a brief review and update of the literature. Curr Opin Ophthalmol. 2006;17:163-7. (Pubitemid 43790812)
26. Tripathi RC, Parapuram SK, Tripathi BJ, Zhong Y, Chalam KV. Corticosteroids and glaucoma risk. Drugs Aging. 1999;15:439-50. (Pubitemid 30025747)
27. Tripathi RC, Tripathi BJ, Haggerty C. Drug-induced glaucomas: mechanism and management. Drug Saf. 2003;26:749-67. (Pubitemid 37056107)
28. Woods AC. Clinical and experimental observation on the use of ACTH and cortisone in ocular inflammatory disease. Trans Am Ophthalmol Soc. 1950;48:259-96.
29. Park JJ, Gole GA. Corticosteroid-induced glaucoma in a child after a scleral reinforcement procedure. Clin Experiment Ophthalmol. 2002;30:372-4. (Pubitemid 35203380)
30. Butcher JM, Austin M, McGalliard J, Bourke RD. Bilateral cataracts and glaucoma induced by long term use of steroid eye drops. BMJ. 1994;309:43. (Pubitemid 24202644)
31. Garbe E, LeLorier J, Boivin JF, Suissa S. Inhaled and nasal glucocorticoids and the risks of ocular hypertension or open-angle glaucoma. JAMA. 1997;277:722-7. (Pubitemid 27106224)
32. Dreyer EB. Inhaled steroid use and glaucoma. N Engl J Med. 1993;329:1822.
33. Mitchell P, Cumming RG, Mackey DA. Inhaled corticosteroids, family history, and risk of glaucoma. Ophthalmology. 1999;106:2301-6. (Pubitemid 30191442)
34. Opatowsky I, Feldman RM, Gross R, Feldman ST. Intraocular pressure elevation associated with inhalation and nasal corticosteroids. Ophthalmology. 1995;102:177-9.
35. Covell LL. Glaucoma induced by systemic steroid therapy. Am J Ophthalmol. 1958;45:108-9.
36. Stern JJ. Acute glaucoma during cortisone therapy. Am J Ophthalmol. 1953;36:389-90.
37. Garbe E, LeLorier J, Boivin JF, Suissa S. Risk of ocular hypertension or open-angle glaucoma in elderly patients on oral glucocorticoids. Lancet. 1997;350:979-82. (Pubitemid 27421106)
38. Eisenlohr JE. Glaucoma following the prolonged use of topical steroid medication to the eyelids. J Am Acad Dermatol. 1983;8:878-81. (Pubitemid 13094710)
39. Sahni D, Darley CR, Hawk JL. Glaucoma induced by periorbital topical steroid use - a rare complication. Clin Exp Dermatol. 2004;29:617-9. (Pubitemid 39573649)
40. Ross JJ, Jacob A, Batterbury M. Facial eczema and sight-threatening glaucoma. J R Soc Med. 2004;97:485-6. (Pubitemid 39424608)
41. Zugerman C, Saunders D, Levit F. Glaucoma from topically applied steroids. Arch Dermatol. 1976;112:1326.
42. Hofman A, Breteler MM, van Duijn CM, et al. The Rotterdam Study: 2010 objectives and design update. Eur J Epidemiol. 2009;24:553-72.
43. Dielemans I, Vingerling JR, Hofman A, Grobbee DE, de Jong PT. Reliability of intraocular pressure measurement with the goldmann applanation tonometer in epidemiological studies. Graefes Arch Clin Exp Ophthalmol. 1994;232:141-4. (Pubitemid 24091732)
44. Skenduli-Bala E, de Voogd S, Wolfs RC, et al. Causes of incident visual field loss in a general elderly population: the Rotterdam Study. Arch Ophthalmol. 2005;123:233-8. (Pubitemid 40189712)
45. Wolfs RC, Borger PH, Ramrattan RS, et al. Changing views on open-angle glaucoma: definitions and prevalences - The Rotterdam Study. Invest Ophthalmol Vis Sci. 2000;41:3309-21.
46. Czudowska MA, Ramdas WD, Wolfs RC, et al. Incidence of glaucomatous visual field loss: a ten-year follow-up from the Rotterdam Study. Ophthalmology. 2010;117:1705-12.
47. Fries JF, Spitz PW, Young DY. The dimensions of health outcomes: the health assessment questionnaire, disability and pain scales. J Rheumatol. 1982;9:789-93.
48. Allison PD. Logistic regression using SAS: theory and application. Cary: SAS Institute and Wiley; 2001. p. 48-51.
49. Vie R. Glaucoma and amaurosis associated with long-term application of topical corticosteroids to the eyelids. Acta Derm Venereol. 1980;60:541-2. (Pubitemid 11197216)
50. Michaeli-Cohen A, Neudorfer M, Loewenstein A, Lazar M, Geyer O. Case report: Visual loss caused by facial steroids. Can Fam Physician. 1998;44:2462-3.
51. McLean CJ, Lobo RF, Brazier DJ. Cataracts, glaucoma, and femoral avascular necrosis caused by topical corticosteroid ointment. Lancet. 1995;345:330.
52. thoe Schwartzenberg GW, Buys YM. Glaucoma secondary to topical use of steroid cream. Can J Ophthalmol. 1999;34:222-5.
53. Bernstein HN, Mills DW, Becker B. Steroid-induced elevation of intraocular pressure. Arch Ophthalmol. 1963;70:15-8.
54. Armaly MF. Effect of corticosteroids on intraocular pressure and fluid dynamics. II. The effect of dexamethasone in the glaucomatous eye. Arch Ophthalmol. 1963;70:492-9.
55. Armaly MF. Effect of corticosteroids on intraocular pressure and fluid dynamics. I. The effect of dexamethasone in the normal eye. Arch Ophthalmol. 1963;70:482-91.
56. Long WF. A case of elevated intraocular pressure associated with systemic steroid therapy. Am J Optom Physiol Opt. 1977;54:248-52. (Pubitemid 8259735)
57. Garrott HM, Walland MJ. Glaucoma from topical corticosteroids to the eyelids. Clin Experiment Ophthalmol. 2004;32:224-6. (Pubitemid 38618415)
58. Nielsen NV, Sorensen PN. Glaucoma induced by application of corticosteroids to the periorbital region. Arch Dermatol. 1978;114:953-4. (Pubitemid 9202413)
59. Aggarwal RK, Potamitis T, Chong NH, Guarro M, Shah P, Kheterpal S. Extensive visual loss with topical facial steroids. Eye (Lond). 1993;7:664-6. (Pubitemid 23328411)
60. Hutcheson KA. Steroid-induced glaucoma in an infant. J AAPOS. 2007;11:522-3. (Pubitemid 47539947)
61. Sasaki R, Suda K, Fukuchi T, et al. A case of steroid-induced glaucoma after radial keratotomy. J Jpn Ophthalmol Soc. 2003;107:213-8.
62. Wax M. Steroid-induced glaucoma in a young woman. J Glaucoma. 1998;7:353-8. (Pubitemid 30246091)
63. Perkins ES. Steroid-induced glaucoma. Proc R Soc Med. 1965;58:531-3.
64. Tham CC, Ng JS, Li RT, Chik KW, Lam DS. Intraocular pressure profile of a child on a systemic corticosteroid. Am J Ophthalmol. 2004;137:198-201. (Pubitemid 38045219)
65. Al-Shahwan S, Khan AO. Buphthalmos following systemic steroid treatment. J Pediatr Ophthalmol Strabismus. 2006;43:311-2. (Pubitemid 44600178)
66. Phillips RP, McLean IC, Taylor RJ, Forrester JV. Steroid induced glaucoma: a report of two cases with a review of morbidity and prescribing in general practice. Scott Med J. 1990;35:81-4. (Pubitemid 20193432)
67. Burde RM, Becker B. Corticosteroid-induced glaucoma and cataracts in contact lens wearers. JAMA. 1970;213:2075-7.
68. Hales RH. Glaucoma induced by careless use of steroids. J Pediatr Ophthalmol. 1973;10:206-7.
69. Baratz KH, Hattenhauer MG. Indiscriminate use of corticosteroid- containing eyedrops. Mayo Clin Proc. 1999;74:362-6. (Pubitemid 29162536)
70. Al-Samarrai AR. Steroid-induced congestive glaucoma. Afro Asian J Ophthalmol. 1993;12:311-2. (Pubitemid 24084018)
71. Kim JH, Kim SM, Park YS. Steroid-induced glaucoma. J Korean Ophthalmol Soc. 1969;10:123-9.
72. Spaeth GL, Rodrigues MM, Weinreb S. Steroid-induced glaucoma: A. persistent elevation of intraocular pressure B. Histopathological aspects. Trans Am Ophthalmol Soc. 1977;75:353-81. (Pubitemid 8335223)
73. Lam DS, Fan DS, Ng JS, Yu CB, Wong CY, Cheung AY. Ocular hypertensive and anti-inflammatory responses to different dosages of topical dexamethasone in children: a randomized trial. Clin Experiment Ophthalmol. 2005;33:252-8. (Pubitemid 41602393)
74. Gonzalez AV, Li G, Suissa S, Ernst P. Risk of glaucoma in elderly patients treated with inhaled corticosteroids for chronic airflow obstruction. Pulm Pharmacol Ther. 2010;23:65-70.